neuromuscular diseases for which a high vector dose is required with natural AAVs, the team demonstrated the efficacy of the new capsid in muscle at a lower dose and without penetrating the liver.

This can cause symptoms such as chest pain ... vector specificity and dosing. Successful gene therapy requires safe and targeted provision of genetic material to the heart muscle, efficient ...